Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif

Biochemical and Biophysical Research Communications

Volumn 322, Issue 1, 2004, Pages 197-202

  Shiraishi, Tetsuya ^a,d   Suzuyama, Kenji ^a   Okamoto, Hiroaki ^a   Mineta, Toshihiro ^a   Tabuchi, Kazuo ^a   Nakayama, Kazuyuki ^b   Shimizu, Yusuke ^b   Tohma, Junko ^b   Ogihara, Takuo ^b   Naba, Hiroyasu ^b   Mochizuki, Hidenori ^b   Nagata, Shigekazu ^c  

^a SAGA UNIVERSITY   (Japan)

^b MOCHIDA PHARMACEUTICAL CO   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d SONY COMPUTER SCIENCE LABORATORIES INC   (Japan)

Author keywords

Apoptosis; Bcl 2; Fas; Glioma; Isoleucine zipper motif; Soluble Fas ligand

Indexed keywords

FAS ANTIGEN; FAS LIGAND; HYBRID PROTEIN; ISOLEUCINE ZIPPER MOTIF; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; RAT;

ANIMALS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BODY WEIGHT; CELL LINE, TUMOR; CELL SURVIVAL; FAS LIGAND PROTEIN; FEMALE; HUMANS; ISOLEUCINE; JURKAT CELLS; LEUCINE ZIPPERS; MEMBRANE GLYCOPROTEINS; ORGAN SIZE; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; SOLUBILITY;

EID: 4143094790     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.098     Document Type: Article

References (34)

1. M.E. Peter, and P.H. Krammer Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis Curr. Opin. Immunol. 10 1998 545 551
2. A. Oehm, I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, H. Ponsting, and P.H. Krammer Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen J. Biol. Chem. 267 1992 10709 10715
3. C. Smith, T. Farrah, and R. Goodwin The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death Cell 76 1994 959 962
4. R. Watanabe-Fukunaga, C.I. Brannan, N. Itoh, S. Yonehara, N.G. Copeland, N.A. Jenkins, and S. Nagata The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen J. Immunol. 148 1992 1274 1279
5. S. Nagata, and P. Golstein The Fas death factor Science 267 1995 1449 1456
6. J.P. Medema, C. Scaffidi, F.C. Kischkel, A. Shevchenko, M. Mann, P.H. Krammer, and M.E. Peter FLICE is activated by association with the CD95 death-inducing signaling complex (DISC) EMBO J. 16 1997 2794 2804
7. N. Thornberry, and Y. Lazebnik Caspases: enemies within Science 281 1998 1312 1316
8. T. Shiraishi, S. Nakagawa, K. Toda, S. Kihara, Y. Ju, and K. Tabuchi Anti-Fas antibody induces apoptosis in cultured glioma cells by activation of the sphingomyelin pathway M. Nagai Brain Tumor Research and Therapy 1996 Springer-Verlag Tokyo 283 291
9. K. Toda, T. Shiraishi, T. Hirotsu, K. Fukuyama, T. Mineta, S. Kawaguchi, and K. Tabuchi The cytocidal activity of OK-432-activated mononuclear cells against human glioma cells is partly mediated through the Fas ligand/Fas system Jpn. J. Cancer Res. 87 1996 972 976
10. M. Weller, U. Malipiero, A. Rensing-Ehl, P.J. Barr, and A. Fontana Fas/APO-1 gene transfer for human malignant glioma Cancer Res. 55 1995 2936 2944
11. S. Kawaguchi, T. Mineta, M. Ichinose, J. Masuoka, T. Shiraishi, and K. Tabuchi Induction of apoptosis in glioma cells by recombinant human Fas ligand Neurosurgery 46 2000 431 438
12. T. Takahashi, M. Tanaka, J. Ogasawara, T. Suda, H. Murakami, and S. Nagata Swapping between Fas and granulocyte colony-stimulating factor receptor J. Biol. Chem. 271 1996 17555 17560
13. J. Dhein, P.T. Daniel, B.C. Trauth, A. Oehm, P. Moller, and P.H. Krammer Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens J. Immunol. 149 1992 3166 3173
14. P. Schneider, N. Holler, J.L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity J. Exp. Med. 187 1998 1205 1213
15. S. Mizushima, and S. Nagata pEF-BOS, a powerful mammalian expression vector Nucleic Acids Res. 18 1990 5322
16. T.P. Hopp, K.S. Prickett, V.L. Price, R.T. Libby, C.J. March, D.P. Cerretti, D.L. Urdal, and P.J. Conlon A short polypeptide marker sequence useful for recombinant protein identification and purification Bio/Technology 6 1988 1204 1210
17. P.B. Harbury, T. Zhang, P.S. Kim, and T. Alber A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants Science 262 1993 1401 1407
18. R. Fukunaga, E. Ishizaka-Ikeda, Y. Seto, and S. Nagata Expression cloning of a receptor for murine granulocyte colony-stimulating factor Cell 61 1990 341 350
19. Y. Kanda, Y. Tanaka, K. Shirakawa, T. Yatomi, N. Nakamura, M. Kami, T. Saito, K. Izutsu, T. Asai, K. Yuji, S. Ogawa, H. Honda, K. Mitani, S. Chiba, Y. Yazaki, and H. Hirai Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease Bone Marrow Transplant. 22 1998 751 754
20. M. Tanaka, T. Suda, T. Takahashi, and S. Nagata Expression of the functional soluble form of human fas ligand in activated lymphocytes EMBO J. 14 1995 1129 1135
21. J. Ogasawara, R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata Lethal effect of the anti-Fas antibody in mice Nature 364 1993 806 809
22. M. Tanaka, T. Suda, T. Yatomi, N. Nakamura, and S. Nagata Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes J. Immunol. 158 1997 2303 2309
23. M. Mizuno, and J. Yoshida Tumor necrosis factor-alpha gene transfer augments anti-Fas antibody-mediated apoptosis in human glioma cells Jpn. J. Cancer Res. 87 1996 543 547
24. S. Kondo, Y. Ishizaka, T. Okada, Y. Kondo, M. Hitomi, Y. Tanaka, T. Haqqi, G.H. Barnett, and B.P. Barna FADD gene therapy for malignant gliomas in vitro and in vivo Hum. Gene Ther. 9 1998 1599 1608
25. N. Shinoura, Y. Yoshida, A. Sadata, K.I. Hanada, S. Yamamoto, T. Kirino, A. Asai, and H. Hamada Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy Hum. Gene Ther. 9 1998 1983 1993
26. K. Aoki, L.M. Akyurek, H. San, K. Leung, M.S. Parmacek, E.G. Nabel, and G.J. Nabel Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy Mol Ther. 1 2000 555 565
27. P.K. Sorger, and H.C. Nelson Trimerization of a yeast transcriptional activator via a coiled-coil motif Cell 59 1989 807 813
28. T. Takakuwa, Z. Dong, S. Nakatsuka, S. Kojya, Y. Harabuchi, W.I. Yang, S. Nagata, and K. Aozasa Frequent mutations of Fas gene in nasal NK/T cell lymphoma Oncogene 21 2002 4702 4705
29. H. Takayama, T. Takakuwa, Y. Tsujimoto, Y. Tani, N. Nonomura, A. Okuyama, S. Nagata, and K. Aozasa Frequent Fas gene mutations in testicular germ cell tumors Am. J. Pathol. 161 2002 635 641
30. G. Ruberti, I. Cascino, G. Papoff, and A. Eramo Fas splicing variants and their effect on apoptosis Adv. Exp. Med. Biol. 406 1996 125 134
31. R.M. Pitti, S.A. Marsters, D.A. Lawrence, M. Roy, F.C. Kischkel, P. Dowd, A. Huang, C.J. Donahue, S.W. Sherwood, D.T. Baldwin, P.J. Godowski, W.I. Wood, A.L. Gurney, K.J. Hillan, R.L. Cohen, A.D. Goddard, D. Botstein, and A. Ashkenazi Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer Nature 396 1998 699 703
32. C. Bai, B. Connolly, M.L. Metzker, C.A. Hilliard, X. Liu, V. Sandig, A. Soderman, S.M. Galloway, Q. Liu, C.P. Austin, and C.T. Caskey Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster Proc. Natl. Acad. Sci. USA 97 2000 1230 1235
33. H. Ungefroren, M.L. Kruse, A. Trauzold, S. Roeschmann, C. Roeder, A. Arlt, D. Henne-Bruns, and H. Kalthoff FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis J. Cell Sci. 114 2001 2735 2746
34. R.R. Bullani, B. Huard, I. Viard-Leveugle, H.R. Byers, M. Irmler, J.H. Saurat, J. Tschopp, and L.E. French Selective expression of FLIP in malignant melanocytic skin lesions J. Invest. Dermatol. 117 2001 360 364